NCT00436527

Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application

MetroGel 1% Hydration Study: A Kinetic Regression Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 26 (actual)
• Sponsor: Galderma R&D · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application.

Detailed description

This eight-hour kinetic regression clinical study was conducted to assess the ability of MetroGel® 1% to deliver moisture to facial skin after a single application as measured by the Corneometer CM 825.

Conditions

• Rosacea

Interventions

Type	Name	Description
DRUG	Metronidazole gel 1%	Applied once to a test site on the right or left cheek (as determined by a randomization design)

Timeline

• Start date: 2006-08-01
• Primary completion: 2006-08-01
• Completion: 2006-08-01
• First posted: 2007-02-19
• Last updated: 2022-07-29

Locations

1 site across 1 country: United States